These efforts have led to the development of various GLP-1 receptor agonists, the most recent being semaglutide and tirzepatide, approved for the treatment of type 2 diabetes in 2018 and 2022, respectively
Ozempic is the most popular brand-name semaglutide medication, available as an injectable (subcutaneous) formulation, to improve glycemic control in adults with type 2 diabetes, reduce the risk of cardiovascular events (heart attack, heart failure, and stroke), and prevent worsening kidney disease or kidney failure
GPR40 may be coupled with the -subunit of the Gq family of G proteins (Gq) and activates phospholipase C (PLC) (Fig
Biochemistry 1984;23:64226
A semaglutide dosage calculator simplifies this process considerably
Zhang B, Cheng Z, Chen J, et al